Form 8-K Kiniksa Pharmaceuticals For: Oct 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Kiniksa (KNSA) PT Raised to $35 at Evercore ISI
October 29, 2024 4:23 PM EDTEvercore ISI analyst Liisa Bayko raised the price target on Kiniksa (NASDAQ: KNSA) to $35.00 (from $30.00) while maintaining a Outperform rating.
The analyst comments "KNSA has a solid Q with $112.2M Arcalyst sales slightly beating consensus of $111.5M. KNSA raised... More
